Picture of Shin Nippon Biomedical Laboratories logo

2395 — Shin Nippon Biomedical Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Table: Shin Nippon Biomedical -2015/16 parent results

May 13 (Reuters)-  
          Shin Nippon Biomedical Laboratories Ltd  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT       
              Mar 31, 2016    Mar 31, 2015   Mar 31, 2017      YEAR        
                 LATEST         YEAR-AGO        COMPANY        COMPANY     
                 RESULTS         RESULTS       FORECAST      H1 FORECAST   
  Sales           9.58            13.27          10.20          4.41       
               (-27.9 pct)     (+5.7 pct)     (+6.5 pct)     (+7.3 pct)    
  Operating   loss 410 mln         1.15                                    
                               (+48.5 pct)                                 
  Recurring   loss 651 mln         2.46         30 mln      loss 463 mln   
                               (+42.3 pct)                                 
  Net             2.43        loss 969 mln      25 mln      loss 643 mln   
  EPS           61.16 yen    loss 24.38 yen    0.62 yen    loss 16.16 yen  
  Ann Div          NIL             NIL                                     
  -Q2 Div          NIL             NIL                                     
  -Q4 Div          NIL             NIL                                     
   
  NOTE - Shin Nippon Biomedical Laboratories Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Shin Nippon Biomedical Laboratories

See all news